Tag: #Global Trends

Key Development A new assessment from former U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb suggests the ongoing cyclosporiasis... Read more

Key Development Johnson & Johnson has announced a proposed US$5.5 billion settlement to resolve approximately 69,000 remaining lawsuits alleging that... Read more

Key Development Not every late stage clinical failure changes the trajectory of a pharmaceutical company, but every unsuccessful trial provides... Read more

Key Development Germany is considering stricter oversight of employee sick leave as rising absenteeism and labour costs fuel concerns among... Read more

Key Development Argenx has agreed to acquire Forte Biosciences in a transaction valued at approximately $2.2 billion, representing one of... Read more

Key Development The European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion recommending marketing... Read more

Key Development The US Food and Drug Administration has approved Outlook Therapeutics' Lytenava for the treatment of wet age related... Read more

Key Development The Democratic Republic of Congo has reported more than 3,000 confirmed Ebola cases, marking a significant milestone in... Read more

Key Development The expanding Cyclospora outbreak in the United States has evolved beyond a routine foodborne illness investigation into a... Read more